RGACX
Price
$85.14
Change
-$0.28 (-0.33%)
Updated
Jun 2 closing price
Net Assets
337.53B
SGNFX
Price
$55.26
Change
-$0.35 (-0.63%)
Updated
Jun 2 closing price
Net Assets
76.58M
Interact to see
Advertisement

RGACX vs SGNFX

Header iconRGACX vs SGNFX Comparison
Open Charts RGACX vs SGNFXBanner chart's image
RGACX vs SGNFX Comparison Chart in %
View a ticker or compare two or three
VS
RGACX vs. SGNFX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGACX is a Hold and SGNFX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 338B vs. SGNFX (76.6M). RGACX (0.00) and SGNFX (0.00) have matching dividends . RGACX was incepted earlier than SGNFX: RGACX (24 years) vs SGNFX (26 years). SGNFX (1.28) is less costly to investors than RGACX (0.93). RGACX is a more actively managed with annual turnover of: 32.00 vs. SGNFX (2.25). RGACX has a lower initial minimum investment than SGNFX: RGACX (250) vs SGNFX (2500). SGNFX (14.49) and RGACX (14.24) have marching annual gain over last year. RGACX (22.53) and SGNFX (22.25) have equivalent 5 years return.
RGACXSGNFXRGACX / SGNFX
Total Expense Ratio0.931.2873%
Annual Report Gross Expense Ratio0.931.2873%
Fund Existence24 years26 years-
Gain YTD10.2914.275241%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets338B76.6M441,253%
Annual Yield % from dividends0.000.00-
Returns for 1 year14.2414.4998%
Returns for 3 years51.0777.7866%
Returns for 5 years22.5322.25101%
Returns for 10 years107.79236.4246%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JVLIX28.54N/A
N/A
JHancock Disciplined Value I
JENYX44.07N/A
N/A
Jensen Quality Growth Y
FBDIX174.97N/A
N/A
Franklin Biotechnology Discovery A
EVUYX20.33N/A
N/A
Allspring Util and Telecomms Inst
RLUSX17.62-0.06
-0.34%
Lazard US Equity Focus R6